Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock

Journal of Infectious Diseases

Volumn 177, Issue 1, 1998, Pages 127-132

  Liaudet, Lucas ^a   Rosselet, Anne ^b   Schaller, Marie Denise ^b   Markert, Michèle ^b   Perret, Claude ^b   Feihl, François ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANAVANINE; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR;

ADJUVANT THERAPY; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME INHIBITION; ESCHERICHIA COLI; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0031985033     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/513813     Document Type: Article

References (33)

1. Szabo C. Alterations in nitric oxide production in various forms of circulatory shock. New Horizons 1995;3:2-32.
2. MacMicking JD, Nathan C, Horn G, et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995;61:641-50.
3. Laubach VE, Shesely EG, Smithies O, Sherman PA. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA 1995;92:10688-92.
4. Szabo C, Southan GJ, Thiemermann C. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 1994;91:12472-6.
5. Ruetten H, Southan GJ, Abate A, Thiemermann C. Attenuation of endotoxin-induced multiple organ dysfunction by 1-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase. Br J Pharmacol 1996;118:261-70.
6. Wu CC, Chen SJ, Szabo C, Thiemermann C, Vane JR. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br J Pharmacol 1995;114:1666-72.
7. Liaudet L, Feihl F, Rosselet A, Markert M, Perret C. Beneficial effects of L-canavanine, a selective inhibitor of inducible nitric oxide synthase, during rodent endotoxemia. Clin Sci 1996;90:369-77.
8. Thiemermann C, Ruetten H, Wu CC, Vane JR. The multiple organ dysfunction syndrome caused by endotoxin in the rat: attenuation of liver dysfunction by inhibitors of nitric oxide synthase. Br J Pharmacol 1995;116:2845-51.
9. Cunha FQ, Assreuy J, Moss DW, et al. Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-α and IL-1β. Immunology 1994;81:211-5.
10. Tracey WR, Tse J, Carter G. Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors. J Pharmacol Exp Ther 1995;272:1011-5.
11. Liaudet L, Fishman D, Feihl F, Markert M, Perret C. L-canavanine improves organ function and tissue adenosine triphosphate levels in rodent endotoxemia. Am J Respir Crit Care Med 1997;155:1643-8.
12. Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 1994;28:34-9.
13. Evans T, Carpenter A, Silva A, Cohen J. Inhibition of nitric oxide synthase in experimental gram-negative sepsis. J Infect Dis 1994;169:343-9.
14. Florquin S, Amraoui Z, Dubois C, Decuyper J, Goldman M. The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice. J Exp Med 1994;180:1153-8.
15. Minnard EA, Shou J, Naama H, Cech A, Gallagher H, Daly JM. Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch Surg 1994;129:142-8.
16. Park JH, Chang SH, Lee KM, Shin SY. Protective effect of nitric oxide in an endotoxin-induced septic shock. Am J Surg 1996;171:340-5.
17. Teale DM, Atkinson M. Inhibition of nitric oxide synthesis improves survival in a murine peritonitis model of sepsis that is not cured by antibiotics alone. J Antimicrob Chemother 1992;30:839-42.
18. Harbrecht BG, Billiar TR, Stadler J, et al. Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia. Crit Care Med 1992;20:1568-74.
19. Spain DA, Wilson MA, Bar-Natan MF, Garrison RN. Role of nitric oxide in the small intestinal microcirculation during bacteremia. Shock 1994;2:41-6.
20. Wright CE, Rees DD, Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992;26:48-57.
21. Shultz P, Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 1992;90:1718-25.
22. Thomas DA, Rosenthal GA. Toxicity and pharmacokinetics of the nonprotein amino acid L-canavanine in the rat. Toxicol Appl Pharmacol 1987;91:395-405.
23. Schmidt HHHW, Zernikow B, Baeblich S, Böhme E. Basal and stimulated formation and release of L-arginine-derived nitrogen oxides from cultured endothelial cells. J Pharmacol Exp Ther 1990;254:591-7.
24. Fishman D, Liaudet L, Lazor R, Feihl F, Perret C. L-canavanine, an inhibitor of inducible nitric oxide synthase, improves venous return in endotoxemic rats. Crit Care Med 1997;25:469-75.
25. Salzman AL. Nitric oxide and the gut. New Horizons 1995;3:33-45.
26. Wu CC, Ruetten H, Thiemermann C. Comparison of the effects of aminoguanidine and N-omega-nitro-L-arginine methyl ester on the multiple organ dysfunction caused by endotoxaemia in the rat. Eur J Pharmacol 1996;300:99-104.
27. Sorrells DL, Friend C, Koltuksuz U, et al. Inhibition of nitric oxide with aminoguanidine reduces bacterial translocation after endotoxin challenge in vivo. Arch Surg 1996;131:1155-63.
28. Aranow JS, Zhuang J, Wang H, Larkin V, Smith M, Fink MP. A selective inhibitor of inducible nitric oxide synthase prolongs survival in a rat model of bacterial peritonitis: comparison with two nonselective strategies. Shock 1996;5:116-21.
29. Szabo C, Bryk R, Zingarelli B, et al. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform. Br J Pharmacol 1996;118:1659-68.
30. Lynn WA, Cohen J. Adjunctive therapy for septic shock: a review of experimental approaches. Clin Infect Dis 1995;20:143-58.
31. Beutler B, Milsark IV, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985;229:869-71.
32. Wakabayashi G, Gelfand JA, Burke JF, Thompson RC, Dinarello CA. A specific receptor antagonist for interleukin-1 prevents Escherichia coli-induced shock in rabbits. FASEB J 1991;5:338-43.
33. Fink MP, Heard SO. Laboratory models of sepsis and septic shock. J Surg Res 1990;49:186-96.